ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1321

Distinguishing Features of Polymicrobial Septic Arthritis

Sarah B. Lieber1, Andy Moore2, Robert Shmerling3, Mary Louise Fowler4 and Ziv Paz1, 1Beth Israel Deaconess Medical Center, Boston, MA, 2Division of Rheumatology, Cambridge Health Alliance, Harvard Medical School, Boston, MA, 3Rheumatology, Beth Israel Deaconess Medical Center, Boston, MA, 4Boston University School of Medicine, Boston, MA

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Clinical research, infection and prosthesis

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2016

Title: Infection-related Rheumatic Disease - Poster

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:  Little is known about patients with polymicrobial septic arthritis (SA) and how they may differ from those with SA due to a single organism. The purpose of this study is to define the demographic features, clinical characteristics, microbiology, and outcomes of patients with polymicrobial SA as compared to those with monomicrobial SA.

Methods:  We conducted a retrospective cohort study of patients 18 years and older admitted to a single tertiary care center from 1998 to 2015 with culture-positive, surgically treated SA affecting one or more joints. Baseline characteristics, clinical features, microbial profile, rate of operative intervention, length of hospital stay (LOS), and 60-day readmission rates were determined. Patients were stratified by presence of SA due to a single organism or more than one organism, identified either in the blood of patients with inflammatory arthritis or in synovial fluid.

Results:  Of 511 patients with SA, 52 (10.2%) were found to have polymicrobial SA. Demographic features were similar in the polymicrobial and monomicrobial SA groups. Of those with polymicrobial SA, 6 had polyarticular involvement, similar to the rate of polyarticular involvement in those with monomicrobial SA. Polymicrobial SA was less commonly preceded by joint trauma (5.9% versus 18.1%; p = 0.03). Those with polymicrobial SA tended to have lower synovial fluid white blood cell counts (SF WBC) (71.2 versus 101.4 x 109 per liter) with significantly lower % polymorphonuclear (PMN) cells (78.1% versus 88.0%; p = 0.003). Polymicrobial SA occurred most frequently in the knee (n = 27) and hip (n = 13), but no differences in joint distribution were found as compared to those with SA due to a single organism. Coagulase negative Staphylococcus (32.7% versus 12.0%; p < 0.001), Enterococci (33% versus 2.5%, p <0.001) and Escherichia Coli ( 15% versus 2.5%, p <0.001) are the three most frequently isolated organism in polymicrobial SA (Figure 1). LOS was longer in those with polymicrobial SA (13.4 versus 10.7 days; p = 0.04), and there was a trend toward more frequent Intensive Care Unit (ICU) stays (25.0% versus 15.9%; p = 0.098). Rates of endocarditis were similar in patients with polymicrobial and monomicrobial SA.

Conclusion:  Patients with polymicrobial SA may differ in important ways from patients with monomicrobial SA. Despite lower SF WBC counts and many infections with bacteria of low virulence, patients with polymicrobial SA may have more severe disease, as suggested by a longer LOS and more frequent transfers to the ICU.


Disclosure: S. B. Lieber, None; A. Moore, None; R. Shmerling, None; M. L. Fowler, None; Z. Paz, None.

To cite this abstract in AMA style:

Lieber SB, Moore A, Shmerling R, Fowler ML, Paz Z. Distinguishing Features of Polymicrobial Septic Arthritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/distinguishing-features-of-polymicrobial-septic-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/distinguishing-features-of-polymicrobial-septic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology